To refer to this page use:
|Abstract:||For early-stage breast cancers mastectomy is an aggressive form of treatment. Therefore, there is a need for new treatment strategies that can enhance the use of lumpectomy by eliminating residual cancer cells with limited side effects to reduce local recurrence. Although, various radiotherapy-based methods have been developed, residual cells are found in 20–55% of the time at the first operation. Furthermore, some current treatment methods result in poor cosmesis. For the last decade, the authors have been exploring the use of polymeric composite materials in single and multi-modal implantable biomedical devices for post-operative treatment of breast cancer. In this paper, the concept and working principles of the devices, as well as selected results from experimental and numerical investigations, are presented. The results show the potential of the biomedical implants for cancer treatment.|
|Citation:||Kan-Dapaah, Kwabena, Nima Rahbar, and Wole Soboyejo. "Polymeric composite devices for localized treatment of early-stage breast cancer." PloS ONE 12, no. 2 (2017): e0172542. doi: 10.1371/journal.pone.0172542|
|Type of Material:||Journal Article|
|Journal/Proceeding Title:||PloS ONE|
|Version:||Final published version. This is an open access article.|
Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.